41 KFSH scientists named among Stanford's top 2% most-cited researchers

Forty-one scientists at King Faisal Specialist Hospital & Research Centre made Stanford/Elsevier’s 2026 Top 2% Scientists list, up from 35 last year. The recognition underscores KFSH’s rising research profile and its push to turn scientific output into healthcare impact in Saudi Arabia.

Why it matters: - The ranking signals stronger global visibility for King Faisal Specialist Hospital & Research Centre’s research output. - The recognition supports KFSH’s role as a leading medical research institution in the Middle East. - The result aligns with Saudi Arabia’s Vision 2030 goal of becoming a global hub for scientific innovation.

What happened: - Forty-one KFSH scientists were named to Stanford/Elsevier’s Top 2% Scientists list of the world’s most-cited researchers. - The 2026 total is six higher than the 35 scientists included in the 2025 list. - Prof. Jackie Y. Ying, chief research and innovation officer, said the increase reflects broader recognition of KFSH researchers and clinician-scientists for publication impact. - KFSH said this is the seventh consecutive year its scientists have appeared on the list.

The details: - Stanford first released the list in 2019 and updates it annually. - The ranking measures citation impact across published work. - The database evaluates more than 180,000 scientists across 22 fields and 174 sub-disciplines. - The list uses two measures: career-long impact and single-year performance. - KFSH said the recognition reflects its success in translating research into practical healthcare applications. - KFSH also said the result adds to its contribution to scientific literature.

Between the lines: - The repeated appearance on the list suggests KFSH has built sustained research depth, not a one-year spike. - The increase from 35 to 41 researchers points to broader output across more scientists, which can strengthen institutional reputation and recruitment. - The recognition adds another external marker to KFSH’s standing in a competitive regional and global healthcare research market. - KFSH is also ranked first in the Middle East and Africa and 12th globally among the world’s top 250 academic medical centers for 2026. - Brand Finance named KFSH the region’s most valuable healthcare brand for 2026. - Newsweek included KFSH in its 2026 lists of the World’s Best Hospitals, Best Smart Hospitals and Best Specialized Hospitals.

What's next: - KFSH is likely to use the latest citation ranking to support its research reputation and innovation agenda. - The hospital’s broader performance indicators suggest continued emphasis on research-driven care and international benchmarking. - Further annual updates to the Stanford/Elsevier list will show whether KFSH can extend its seven-year streak and widen its researcher base.

The bottom line: - KFSH’s latest citation ranking shows growing research reach and reinforces the hospital’s position as a regional leader with global academic influence.